A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)

Clinical trial NCT01155479 · TERMINATED

Trial details

NCT number: NCT01155479
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2010-07-06
Primary completion: 2013-07-16
Enrollment: 1022

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.